NDAORALTABLET, EXTENDED RELEASEPriority Review
Approved
Mar 2025
Lifecycle
Launch
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities
Started Jan 2023
30 enrolled
SH2B1 Deficiency ObesityObesity Associated With PCSK1 Mutation (rs6232 Variant)SIM1 Deficiency Obesity
A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
Started May 2018
127 enrolled
Prader-Willi Syndrome
Loss of Exclusivity
LOE Date
Nov 12, 2035
118 months away
Patent Expiry
Nov 12, 2035
Exclusivity Expiry
Mar 26, 2028